Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114709) titled 'Study on the Characteristics and Cellular Origins of the Sebaceous Gland' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: WUHAN UNIVERSITY
Condition:
Atopic Dermatitis
Intervention:
Rosiglitazone treatment group:Topical application of an ointment containing rosiglitazone
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-12-22
Target Sample Size: Rosiglitazone treatment group:10;Vehicle control group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=290105
Published by HT Digital...